Cargando…

Optimal frequency of scans for patients on cancer therapies: A population kinetics assessment

BACKGROUND: Optimal frequency of follow‐up scans for patients receiving systemic therapies is poorly defined. Progression‐free survival (PFS) generally follows first‐order kinetics. We used exponential decay nonlinear regression analysis to calculate half‐lives for 887 published PFS curves. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, David J., Macdonald, David B., Awan, Arif A., Thavorn, Kednapa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853816/ https://www.ncbi.nlm.nih.gov/pubmed/31560842 http://dx.doi.org/10.1002/cam4.2571

Ejemplares similares

The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment
por: Stewart, David J., et al.
Publicado: (2021)

High frequency of brain metastases after adjuvant therapy for high‐risk melanoma
por: Samlowski, Wolfram E., et al.
Publicado: (2017)

Assessing evidence of interventions addressing inequity among migrant populations: a two-stage systematic review
por: Yadee, Jirawit, et al.
Publicado: (2019)

Optimal surgical timing and radiotherapy dose for trimodality therapy in locally advanced non‐small cell lung cancer
por: Han, James E., et al.
Publicado: (2021)

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)
por: Thébaud, Bernard, et al.
Publicado: (2021)

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
por: Porat, Yaara, et al.
Publicado: (2017)

PD-1 as a potential target in cancer therapy
por: McDermott, David F, et al.
Publicado: (2013)

Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma
por: Eggen, Annemarie C., et al.
Publicado: (2021)

The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
por: Phillips, William J., et al.
Publicado: (2022)

Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy
por: Chennupati, Sravana K, et al.
Publicado: (2014)

Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)

Development and validation of the functional assessment of cancer therapy–antiangiogenesis subscale
por: Kaiser, Karen, et al.
Publicado: (2015)

The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada
por: Black, Cody D., et al.
Publicado: (2019)

Duration of therapy for locally advanced pancreatic cancer: Does it matter?
por: Tuli, Richard, et al.
Publicado: (2020)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

Assessment of the prognostic factors in patients with pulmonary carcinoid tumor: a population‐based study
por: Huang, Yiwei, et al.
Publicado: (2018)

Predictive model for high‐frequency microsatellite instability in colorectal cancer patients over 50 years of age
por: Fujiyoshi, Kenji, et al.
Publicado: (2017)

Determining the hospital cost of anterior epistaxis treatment modalities at a Canadian tertiary care centre
por: Nithianandan, Harrish, et al.
Publicado: (2019)

Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy
por: Mas-Ponte, David, et al.
Publicado: (2022)

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast cancer
por: Zhao, Yannan, et al.
Publicado: (2020)

Non-invasive detection of corneal sub-basal nerve plexus changes in multiple myeloma patients by confocal laser scanning microscopy
por: Koschmieder, Anita, et al.
Publicado: (2020)

Data‐driven analysis of JAK2V617F kinetics during interferon‐alpha2 treatment of patients with polycythemia vera and related neoplasms
por: Pedersen, Rasmus K., et al.
Publicado: (2020)

Abnormal bowel movement frequency increases the risk of rectal cancer: evidence from cohort studies with one million people
por: Shen, Lin, et al.
Publicado: (2020)

Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models
por: Raghu, Vineet K, et al.
Publicado: (2019)

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study
por: Qiu, Miao‐Zhen, et al.
Publicado: (2018)

Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia
por: Patel, Manish I, et al.
Publicado: (2015)

Health system costs of potentially inappropriate prescribing in Ontario, Canada: a protocol for a population-based cohort study
por: Black, Cody D, et al.
Publicado: (2018)

Role of medical imaging for immune checkpoint blockade therapy: From response assessment to prognosis prediction
por: Wei, Hong, et al.
Publicado: (2019)

Cause‐specific mortality in HPV+ and HPV− oropharyngeal cancer patients: insights from a population‐based cohort
por: Nørregaard, Cecilie, et al.
Publicado: (2017)

Environmental scan of anal cancer screening practices: worldwide survey results
por: Patel, Jigisha, et al.
Publicado: (2014)

Optimal management of cervical cancer in HIV-positive patients: a systematic review
por: Ntekim, Atara, et al.
Publicado: (2015)

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population‐based cohort study
por: Ording, Anne G., et al.
Publicado: (2017)

Meta‐analysis of first‐line therapies with maintenance regimens for advanced non‐small‐cell lung cancer (NSCLC) in molecularly and clinically selected populations
por: Tan, Pui San, et al.
Publicado: (2017)

COVID-19 Pandemic: Did Strict Mobility Restrictions Save Lives and Healthcare Costs in Maharashtra, India?
por: Ambade, Preshit Nemdas, et al.
Publicado: (2023)

Assessing patients’ risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?
por: Lyman, Gary H, et al.
Publicado: (2015)

Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance
por: Jotte, Robert M, et al.
Publicado: (2015)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u5u3f9vd4sr01rk51052gid3su